This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It acts as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH), which plays a significant role in the metabolism of epoxyeicosatrienoic acids (EETs). By inhibiting sEH, it helps in maintaining the levels of EETs, which are known for their anti-inflammatory, vasodilatory, and cardioprotective effects. This makes it a promising candidate for the development of therapeutic agents targeting cardiovascular diseases, hypertension, and inflammatory disorders. Additionally, its unique adamantane and piperidine structure contributes to its stability and bioavailability, enhancing its potential as a drug candidate.